The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing real-world treatment patterns and outcomes of zanubrutinib and acalabrutinib in CLL/SLL at University of California academic health centers.
 
Aryan Ayati
Research Funding - BeiGene (Inst); Genentech (Inst)
 
Gregory Maglinte
Employment - BeOne Medicines Ltd; BeOne Medicines Ltd (I); Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Amgen; Amgen (I); BeOne Medicines Ltd; BeOne Medicines Ltd (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Gilead Sciences; Gilead Sciences (I); Regeneron; Regeneron (I)
Research Funding - BeOne Medicines Ltd
Travel, Accommodations, Expenses - BeOne Medicines Ltd; BeOne Medicines Ltd (I); Regeneron; Regeneron (I)
 
Marjan Massoudi
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Qianhong Fu
Employment - Abbvie; Abbvie (I); Amgen; Amgen (I); BeOne Medicines Ltd; BeOne Medicines Ltd (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I); Amgen; Amgen (I); BeOne Medicines Ltd; BeOne Medicines Ltd (I)
 
Rhys Williams
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Madhav Seshadri
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Kite, a Gilead company
Research Funding - Genentech/Roche (Inst); Kyverna Therapeutics (Inst); Loxo/Lilly (Inst)
 
Vivek Rudrapatna
Employment - Cityblock Health (I)
Honoraria - DataUnite; ZebraMD; Ironwood; Natera
Consulting or Advisory Role - Acucare
Research Funding - JnJ; Merck; Genentech; Stryker; Mitsubishi Tanabe; Blueprint Medicines; Beigene
 
Michelle Wang
Research Funding - Amgen (Inst); BeiGene (Inst)